SPATIAL TRANSCRIPTOMICS IDENTIFIES SPARC AS A PROGNOSTIC BIOMARKER IN UNCLASSIFIABLE INTERSTITIAL LUNG DISEASES

Takayuki Niitsu; Toshiaki Kataoka; Kiyoharu Fukushima; Daisuke Motooka; Shigeyuki Shichino; Yayoi Natsume‐Kitatani; Hideya Kitamura; Takashi Niwa; Tomohisa Baba; Daisuke Okuzaki; Atsushi Kumanogoh; Akira Shizuo; Koji Okudela; Takashi Ogura

doi:10.1016/j.chest.2025.07.2072

Related publications

Article2025

Spatial transcriptomics identifies <scp>SPARC</scp> as a prognostic marker in interstitial lung diseases

Takayuki Niitsu, Toshiaki Kataoka, Kiyoharu Fukushima, Daisuke Motooka, Shigeyuki Shichino, Yayoi Natsume‐Kitatani, Hideya Kitamura, Takashi Niwa, Tomohisa Baba, Daisuke Okuzaki, Atsushi Kumanogoh, Akira Shizuo, Koji Okudela, Takashi Ogura

Article1998

8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases

Paolo Montuschi, GIOVANNI CIABAT TONI, Paolo Paredi, Panagiotis Pantelidis, Roland M. du Bois, Sergei A. Kharitonov, Peter J Barnes

Article2011

Interstitial lung diseases in a lung cancer screening trial

Nicola Sverzellati, L. Guerci, G. Randi, Elisa Calabrò, Carlo La Vecchia, Alfonso Marchianò, Alberto Pesci, Maurizio Zompatori, Ugo Pastorino

Article2012

suPAR as a prognostic biomarker in sepsis

Katia Donadello, Sabino Scolletta, Cecilia Covajes, Jean Louis Vincent

Article2025

CBFA2T3 as a Key Prognostic Biomarker in Lung Adenocarcinoma: Insights from Comprehensive Analysis and Validation

Jianbo Xiao, Kexin Luo, Meihan Liu, Haiyang Zhao, Yuanze Cai, Yan Gui, Hongpan Zhang